Charles Schwab’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $478K | Buy |
74,165
+6,158
| +9% | +$40.7K | ﹤0.01% | 3244 |
|
|
2026
Q1 | $420K | Sell |
68,007
-9,579
| -12% | -$59.1K | ﹤0.01% | 3160 |
|
|
2025
Q4 | $521K | Buy |
77,586
+130
| +0.2% | +$975 | ﹤0.01% | 3152 |
|
|
2025
Q3 | $633K | Hold |
77,456
| – | – | ﹤0.01% | 3099 |
|
|
2025
Q2 | $545K | Buy |
77,456
+3,730
| +5% | +$25.1K | ﹤0.01% | 3110 |
|
|
2025
Q1 | $526K | Hold |
73,726
| – | – | ﹤0.01% | 3066 |
|
|
2024
Q4 | $676K | Hold |
73,726
| – | – | ﹤0.01% | 3051 |
|
|
2024
Q3 | $715K | Hold |
73,726
| – | – | ﹤0.01% | 3030 |
|
|
2024
Q2 | $599K | Buy |
73,726
+3,785
| +5% | +$29.3K | ﹤0.01% | 3118 |
|
|
2024
Q1 | $564K | Hold |
69,941
| – | – | ﹤0.01% | 2976 |
|
|
2023
Q4 | $384K | Buy |
69,941
+12,101
| +21% | +$63.9K | ﹤0.01% | 3166 |
|
|
2023
Q3 | $302K | Sell |
57,840
-102,293
| -64% | -$727K | ﹤0.01% | 3212 |
|
|
2023
Q2 | $1.85M | Sell |
160,133
-11,203
| -7% | -$132K | ﹤0.01% | 2574 |
|
|
2023
Q1 | $2.14M | Sell |
171,336
-1,017
| -0.6% | -$19.5K | ﹤0.01% | 2511 |
|
|
2022
Q4 | $3.4M | Buy |
172,353
+4,177
| +2% | +$89.9K | ﹤0.01% | 2394 |
|
|
2022
Q3 | $4.08M | Buy |
168,176
+16,255
| +11% | +$449K | ﹤0.01% | 2318 |
|
|
2022
Q2 | $3.67M | Buy |
151,921
+3,872
| +3% | +$103K | ﹤0.01% | 2319 |
|
|
2022
Q1 | $4.8M | Buy |
148,049
+3,494
| +2% | +$110K | ﹤0.01% | 2301 |
|
|
2021
Q4 | $4.92M | Buy |
144,555
+6,129
| +4% | +$223K | ﹤0.01% | 2365 |
|
|
2021
Q3 | $5.96M | Buy |
138,426
+8,146
| +6% | +$501K | ﹤0.01% | 2289 |
|
|
2021
Q2 | $8.49M | Buy |
130,280
+4,893
| +4% | +$310K | ﹤0.01% | 2082 |
|
|
2021
Q1 | $6.59M | Buy |
125,387
+3,679
| +3% | +$184K | ﹤0.01% | 2160 |
|
|
2020
Q4 | $5.44M | Buy |
121,708
+693
| +0.6% | +$23.9K | ﹤0.01% | 2176 |
|
|
2020
Q3 | $3.51M | Sell |
121,015
-1,192
| -1% | -$37.4K | ﹤0.01% | 2244 |
|
|
2020
Q2 | $4.34M | Buy |
122,207
+7,834
| +7% | +$330K | ﹤0.01% | 2092 |
|
|
2020
Q1 | $5.91M | Buy |
114,373
+2,562
| +2% | +$123K | ﹤0.01% | 1751 |
|
|
2019
Q4 | $7.64M | Buy |
111,811
+1,884
| +2% | +$118K | ﹤0.01% | 1801 |
|
|
2019
Q3 | $5.27M | Sell |
109,927
-30,270
| -22% | -$1.58M | ﹤0.01% | 1932 |
|
|
2019
Q2 | $9.36M | Buy |
140,197
+3,906
| +3% | +$297K | 0.01% | 1630 |
|
|
2019
Q1 | $13M | Buy |
136,291
+9,028
| +7% | +$1.13M | 0.01% | 1419 |
|
|
2018
Q4 | $15.8M | Buy |
127,263
+1,443
| +1% | +$238K | 0.01% | 1140 |
|
|
2018
Q3 | $30.7M | Buy |
125,820
+34,449
| +38% | +$7.97M | 0.02% | 845 |
|
|
2018
Q2 | $17M | Buy |
91,371
+6,185
| +7% | +$1.03M | 0.01% | 1211 |
|
|
2018
Q1 | $10.5M | Buy |
85,186
+5,586
| +7% | +$682K | 0.01% | 1461 |
|
|
2017
Q4 | $9.48M | Buy |
79,600
+2,327
| +3% | +$256K | 0.01% | 1510 |
|
|
2017
Q3 | $7.35M | Buy |
77,273
+5,917
| +8% | +$570K | 0.01% | 1659 |
|
|
2017
Q2 | $6.81M | Buy |
71,356
+655
| +0.9% | +$56K | 0.01% | 1621 |
|
|
2017
Q1 | $5.48M | Buy |
70,701
+6,079
| +9% | +$421K | 0.01% | 1710 |
|
|
2016
Q4 | $4.34M | Sell |
64,622
-4,762
| -7% | -$294K | ﹤0.01% | 1823 |
|
|
2016
Q3 | $4.16M | Buy |
69,384
+9,308
| +15% | +$519K | ﹤0.01% | 1764 |
|
|
2016
Q2 | $3.01M | Sell |
60,076
-19,096
| -24% | -$911K | ﹤0.01% | 1868 |
|
|
2016
Q1 | $3.56M | Buy |
79,172
+1,001
| +1% | +$35.7K | ﹤0.01% | 1724 |
|
|
2015
Q4 | $3.13M | Buy |
78,171
+34,917
| +81% | +$1.48M | ﹤0.01% | 1818 |
|
|
2015
Q3 | $2.1M | Buy |
43,254
+21,456
| +98% | +$1.02M | ﹤0.01% | 2040 |
|
|
2015
Q2 | $973K | Buy |
21,798
+14,198
| +187% | +$545K | ﹤0.01% | 2428 |
|
|
2015
Q1 | $244K | Hold |
7,600
| – | – | ﹤0.01% | 2902 |
|
|
2014
Q4 | $239K | Buy |
+7,600
| New | +$184K | ﹤0.01% | 2929 |
|
Other funds holding INGN
AC
DCM
Charles Schwab's INGN Position: Q2 2026 in Review
Charles Schwab increased its Inogen (INGN) stake by 9.1% in Q2 2026, buying an estimated $40.7K and bringing the position to 74,165 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #3244.
Charles Schwab first reported a position in INGN in Q4 2014 and has held it in 47 quarters since. The position peaked at $30.7M in Q3 2018. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.
- Charles Schwab held 74,165 shares of Inogen worth $478K as of Q2 2026.
- Charles Schwab bought 6,158 Inogen shares in Q2 2026, an estimated $40.7K.
- Inogen made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3244 holding.
- Charles Schwab first reported a position in Inogen in Q4 2014 and has held it in 47 quarters since.
- Charles Schwab's Inogen position peaked at $30.7M in Q3 2018.
- 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.